The study found that by using this ultrasound technology on test mice, a 75% memory function was fully restored.

For some time, we've known that it's rare to see people with both cancer and Alzheimer's disease. Now, scientists believe ...

An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to form plaques that collect between neurons and disrupt cell function. - ...

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.

In Alzheimer's disease, proteins like amyloid beta form clumps, known as plaques, that damage the brain. But in some people, immune cells called microglia break down these proteins before they can ...

Amyloid beta is a peptide that plays a central role in the neurodegenerative pathology of Alzheimer’s disease by aggregating into plaques in the brain. U.S. Food and Drug Administration (FDA) approved ...

Leqembi and Kisunla don’t just reduce amyloid plaques that are implicated in Alzheimer’s disease. According to new research, the drugs boost levels of a healthy form of amyloid beta (Aβ42) protein in ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

Scientists have long observed that cancer patients have a lower risk of Alzheimer’s disease. New research reveals a possible reason why.

A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according to new research. Scientists have found that a byproduct of amyloid-beta ...

Cancer and Alzheimer's are two of the most common chronic diseases associated with aging. For years, doctors have known about ...

In Alzheimer's disease, proteins like amyloid beta form clumps, known as plaques, that damage the brain. Subscribe to our newsletter for the latest sci-tech news updates. But in some people, immune ...